Recent media coverage about Borrelia miyamotoi has prompted some questions about prevalence of the bacteria in the UK and risk to human health. In this Q&A, PHE scientists answer questions about the bacteria which has been dubbed responsible for the …
Matthew Dryden (MA, MD, FRCPath, FFTM RCPS (Glasg), FRGS), has been a consultant specialising in microbiology and infectious disease for the past 25 years. He now divides his time between the PHE Rare and Imported Pathogens laboratory at Porton Down and the Hampshire Hospitals NHS Foundation Trust. He has a long-term interest in travel and tropical medicine. Recent research interests include staphyloccal infection and antimicrobial resistance and stewardship.
In the past Matthew has been an expedition doctor on expeditions in varied parts of the world including Africa and Central America. He has worked as a doctor in Sudan and Australia. He is a Fellow of the Royal Geographical Society and a founder member of its Medical Cell. He has recently been General Secretary of the British Society of Antimicrobial Chemotherapy. He has published extensively on travel medicine, microbiology and infectious disease.
Related content and links
About this blog
The official blog of the UK Health Security Agency, providing expert insight on the organisation's work and all aspects of health security.